stockrow
Friday 6 November 2026
Export GEVO’s income statement to Excel — free account
Gevo, Inc.
GEVO Basic Materials Specialty Chemicals
Gevo, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $160.6 million, up 849.3% from fiscal 2024.
- Revenue
- +7.11%
- EPS
- −7,600.0%
- Free cash flow
- −167.5%
- Total debt
- +20.0%
Quarter to June 2026, against a year earlier
1.39
0.17
+13.93%
Follow GEVO
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
3.77 | 2.91 | 3.71 | 2.00 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(67.21) | 23.45 | (30.58) | (42.97) | |
P/B ratio |
0.97 | 1.00 | 1.44 | 1.30 | |
Price to Tangible BV |
1.32 | 1.43 | 1.88 | 2.25 | |
EV/Sales |
4.61 | 3.68 | 4.60 | 3.00 | |
EV/EBITDA |
0.00 | 65.13 | 31.27 | 0.00 | |
EV/Operating CF |
(10.68) | (44.12) | (76.51) | (32.82) | |
EV/FCF |
(6.50) | (13.58) | (18.39) | (9.41) | |
Quick Ratio |
1.52 | 1.51 | 3.30 | 1.86 | |
Current Ratio |
1.91 | 1.82 | 4.31 | 2.70 | |
Net Debt/EBITDA |
6.59 | 9.97 | 33.77 | (0.66) | |
Debt/Assets |
19.65% | 22.97% | 25.58% | 34.21% | |
Debt/Equity |
0.29 | 0.35 | 0.37 | 0.61 | |
Asset Turnover |
0.19 | 0.25 | 0.26 | 0.30 | |
Operating CF/Net income |
0.85 | (3.17) | 0.97 | 0.05 | |
Capex/Depreciation |
(0.90) | (1.45) | (1.18) | (2.04) | |
Interest Coverage |
(0.71) | (0.46) | (0.95) | (30.49) | |
Research and Development Expense of Revenue |
10.54% | 8.56% | 10.57% | 6.11% | |
Selling, General and Administrative Expense of Revenue |
27.27% | 39.00% | 37.75% | 27.70% | |
Intangible Assets out of Total Assets |
0.18 | 0.19 | 0.16 | 0.23 | |
Share Based Compensation of Revenue |
5.53% | 5.96% | 4.90% | 5.50% | |
Graham Net Nets |
(0.17) | (0.23) | (0.14) | (0.33) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(10.20%) | (6.74%) | (4.93%) | (59.65%) | |
Free Cash Flow Yield |
(18.80%) | (9.30%) | (6.75%) | (15.93%) | |
Revenue per Share |
0.18 | 0.19 | 0.18 | 0.20 | |
Operating CF per Share |
(0.03) | 0.09 | (0.09) | (0.03) | |
Capex per Share |
(0.03) | (0.05) | (0.04) | (0.05) | |
Free Cash Flow per Share |
(0.06) | 0.04 | (0.13) | (0.09) | |
Cash per Share |
0.44 | 0.47 | 0.33 | 0.25 | |
Shareholders Equity per Share |
2.02 | 1.99 | 1.89 | 1.15 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.02 | 1.99 | 1.89 | 1.15 | |
Free Cash Flow |
(14.62) | 8.75 | (30.01) | (20.77) | |
Working Capital |
65.05 | 64.82 | 88.97 | 63.96 | |
Capital Expenditures |
(7.83) | (11.21) | (8.87) | (12.49) | |
Net Current Asset Value |
(79.63) | (109.19) | (89.89) | (115.95) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.18 | 0.25 | 0.21 | 0.27 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
4.58 | 5.40 | 10.74 | 11.50 | |
Average Payables |
33.22 | 29.26 | 27.36 | 38.42 | |
Average Inventory |
13.88 | 11.79 | 19.19 | 18.12 | |
Average Assets |
644.50 | 651.44 | 665.65 | 596.42 | |
Average Common Equity |
486.80 | 477.91 | 458.79 | 373.63 |
Columns are period end dates